Gastroenterology & Internal Medicine & Family Medicine
Mucus in the stool
The presence of mucus in stool (mucus in the stool) is a frequent reason for consultation in family medicine. Intestinal mucus is a translucent or white gelatinous substance, normally and continuously produced by goblet cells in the intestinal lining. It plays a crucial protective role: lubricating intestinal transit, acting as a physical barrier against pathogens, moisturizing the lining, and maintaining the gut microbiome. Therefore, a certain amount of mucus in the stool is physiological and normal, usually imperceptible to the naked eye. It is the presence of mucus visible to the naked eye, in large quantities, persistent, or accompanied by other symptoms (abdominal pain + rectal bleeding + diarrhea + fever + weight loss + general deterioration) that should raise concern and lead to investigation. The causes of visible mucus in stool are very varied, ranging from benign (irritable bowel syndrome - the most frequent cause) to potentially serious (colorectal cancer + IBD + severe infection + villous polyp). The diagnostic approach is based on the patient interview (age + medical history + duration + nature of symptoms + risk factors) + clinical examination (digital rectal exam is mandatory) + appropriate further investigations (blood tests + stool culture + colonoscopy depending on red flags). The patient's age, the presence or absence of blood associated with mucus, and red flags guide the urgency of the diagnostic approach.
Physiology of intestinal mucus, classification, and main etiologies
- Physiology of Intestinal Mucus and Mechanisms of Increased Production: Normal physiology of intestinal mucus: Goblet cells continuously secrete mucins (glycoproteins—mainly MUC2 in the colon) → form a bilayer mucosal layer: outer layer (loose—accessible to bacteria + nutrients) + inner layer (dense + protective + impermeable) → protects the mucosa from mechanical + chemical + microbiological aggressions → thickness of the mucosal layer: 100–800 µm depending on the colon region → normal amount in stool: negligible + imperceptible to the naked eye → mechanisms for increased mucus production: mucosal inflammation (IBD + infections) → goblet cell activation → mucin hypersecretion → visible mucus in stool + reactive hypersecretion to irritation (IBS + constipation + defecation straining) + pathological secretions from mucinous tumors (mucinous carcinoma + villous adenoma) → abundant + fecaloid + characteristic mucus + response to infectious agents (enterotoxigenic E. coli + Campylobacter + Salmonella + Shigella + Clostridium difficile + Entamoeba histolytica) → mucosal destruction + inflammation → mucus + mucus strings + pus → dysentery
- Main etiologies and clinical approach: Classification of causes of mucus in stool by frequency and clinical context: **Benign and Common Causes:** * **Irritable Bowel Syndrome (IBS):** Most frequent cause of mucus in stool without blood. Translucent or white mucus in small amounts, associated with abdominal pain, changes in bowel habits (diarrhea, constipation, or alternating), no alarm symptoms, no weight loss, and no bleeding. * **Chronic Constipation and Repeated Straining:** Reactive mucus hypersecretion. * **Internal Hemorrhoids:** Muco-bloody discharge. * **Anal Fissure** * **Diverticular Disease (with mild inflammation)** **Infectious Causes:** * **Bacterial Infectious Gastroenteritis (Salmonella, Campylobacter, Shigella, E. coli O157:H7)** * **Parasitic Infectious Gastroenteritis (Giardia, Entamoeba histolytica - amebiasis):** Mucus and frequent blood, trophozoites or cysts in stool. * **Clostridium difficile (after antibiotic therapy):** Pseudomembranous colitis. Mucus, abundant diarrhea, fever, abdominal pain. **Inflammatory Causes:** * **Inflammatory Bowel Disease (IBD):** * **Crohn's Disease (CD):** Mucus, possible blood, diarrhea, abdominal pain, weight loss, fever, extraintestinal manifestations (joint, skin, ocular). * **Ulcerative Colitis (UC):** Mucus, significant blood (rectal bleeding mixed with stool), tenesmus, diarrhea, abdominal pain. **Red Flags (Colorectal Cancer, Polyps):** * **Colorectal Cancer/Polyps:** Mucus, blood, rectal bleeding in a patient over 50 years old, or with a family history of colorectal cancer, or with weight loss, or with general poor health (AEG), or iron deficiency anemia on CBC. Mandatory colonoscopy. * **Villous Rectal Polyp:** Mucus hypersecretion, sometimes very abundant (several liters/day in giant villous polyps - Verner-Morrison syndrome or rectosigmoid villous polyp syndrome). Watery mucus, hypokalemia. Cause of extremely large amounts of mucus.
Investigation and management according to etiology
| Cause / Approach | Investigation and treatment | References and recommendations |
|---|---|---|
| Diagnostic approach according to red flags Interrogation: Age - Red flags: Blood in stool, unexplained weight loss (AEG), fever, family history of cancer - Rectal exam mandatory - CBC, ferritin, CRP - Stool culture - Fecal calprotectin - Colonoscopy - Sigmoidoscopy - CT scan - Hemoccult test - PAQ |
Diagnostic approach to mucus in the stool: targeted history-taking: age (≥50 years → rule out colorectal cancer) + duration and nature (transient vs. chronic) + presence of blood (melena + rectal bleeding) + abdominal pain + bowel dysfunction + fever + weight loss + loss of appetite + family history of colorectal cancer + polyposis + IBD + infectious context (travel + recent antibiotic therapy) → clinical examination: abdominal palpation + MANDATORY digital rectal exam (rectal mass + blood on the glove + pain) → investigations based on red flags: no red flags (young patient + intermittent mucus + IBS context): no urgent investigations → empirical treatment for IBS → re-evaluate if symptoms persist → with red flags (blood + weight loss + abdominal pain + age >45 years + family history + persistent fever): Complete blood count + ferritin + ESR + CRP + liver function tests → iron-deficiency anemia → cancer or IBD + fecal calprotectin: marker of intestinal inflammation (sensitivity 83% % + specificity 84% % for distinguishing IBD from IBS) → if elevated (>50 µg/g) → endoscopic investigation → stool culture + parasitological stool tests (EPS × 3): if infection is suspected (travel history + immunosuppression + exposure) + fecal occult blood test (Hemoccult + fecal immunochemical test — FIT): colorectal cancer screening in asymptomatic populations → Quebec Colorectal Cancer Screening Program (PQDCC): FIT every 2 years for individuals aged 50–74 → if positive → colonoscopy → colonoscopy: gold standard for direct visualization + biopsies + histological diagnosis + if red flags + or positive FIT + or elevated calprotectin + age >45 years + or family history of colorectal cancer + abdominal-pelvic CT scan: if mass + complications + assessment of cancer spread | Rex 2017 — American Journal of Gastroenterology (ACG guidelines): colorectal cancer + colonoscopy + screening + Lichtenstein 2018 — American Journal of Gastroenterology: IBD + diagnosis + treatment + Tibble 2002 — Gastroenterology: fecal calprotectin + IBD vs IBS → reference + Meads 2021 — Cochrane: fecal calprotectin + IBD vs IBS → + ACG 2021: IBS + Rome IV criteria + diagnosis + PQDCC (Quebec Colorectal Cancer Screening Program): FIT + screening 50–74 years + INESSS Quebec + RAMQ: colonoscopy + CBC + stool culture + calprotectin → reimbursed if indicated |
| IBD, IBD, and infections — etiology-based treatment Rome IV criteria — antispasmodics — FODMAP diet — probiotics — IBD mesalazine — corticosteroids — azathioprine — biotherapies — C. difficile vancomycin fidaxomicin — amebiasis metronidazole — stool culture — targeted antibiotic therapy — villous adenoma endoscopic resection |
Treatment based on the cause of mucus in the stool: irritable bowel syndrome (IBS) — treatment of functional mucus: Rome IV criteria: recurrent abdominal pain ≥1 day/week for ≥3 months + associated with at least 2 of the following criteria: defecation + change in stool frequency + change in stool consistency → mucus = a common associated symptom of IBS + non-pharmacological treatment: low-FODMAP diet (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) → reduces symptoms in 50–70% of IBS patients → education + stress management + physical activity + pharmacological: antispasmodics (enteric-coated peppermint + otilonium + mebeverine) → reduce colic spasms + osmotic laxatives (if constipation is predominant) + loperamide (if diarrhea is predominant) + rifaximin (non-absorbable antibiotic — IBS with predominant diarrhea) + probiotics (moderate evidence) + IBD (Crohn’s + UC) — etiological treatment: treatment of acute flare-ups (mild to moderate ulcerative colitis): mesalazine (5-ASA) 2–4 g/day PO or suppositories/enema if distal form → corticosteroids if response is insufficient (prednisone 40–60 mg/day) → maintenance therapy: mesalazine (prevents relapses in UC) → azathioprine or 6-MP if frequent relapses → biologics (infliximab + adalimumab + vedolizumab + ustekinumab) for moderate to severe refractory forms → according to ECCO + CCFC (Crohn’s and Colitis Canada) + INESSS guidelines → intestinal infections: Clostridium difficile (pseudomembranous colitis): discontinue the causative antibiotic → oral vancomycin 125 mg × 4/day × 10 days (mild to moderate forms) + fidaxomicin 200 mg × 2/day × 10 days (superior for reducing relapses) + treatment of recurrences: bezlotoxumab + fecal microbiota transplantation (FMT) → amebiasis (Entamoeba histolytica): metronidazole 750 mg × 3/day × 5–10 days + luminal paromomycin after (cyst elimination) → Campylobacter / Salmonella: often self-limiting → azithromycin if severe or in immunocompromised patients → rectosigmoid villous polyp: endoscopic resection (mucosectomy + endoscopic submucosal dissection) or surgical resection if not resectable endoscopically → normalization of mucus after resection | Lichtenstein 2018 — ACG guidelines: IBD + treatment + mesalamine + corticosteroids + Sandborn 2019 — NEJM: ustekinumab + Crohn's + outcome → ECCO guidelines 2019 + CCFC (Crohn's and Colitis Canada): IBD + treatment + Feuerstein 2022 — Gastroenterology: IBD + biologics + Johnson 2021 — Lancet: C. difficile + fidaxomicin + vancomycin + Wilcox 2017 — NEJM: bezlotoxumab + C. difficile recurrence + Staudacher 2011 — Journal of Human Nutrition and Dietetics: FODMAP diet + IBS + symptom reduction + ACG 2021: IBS + Rome IV criteria + treatment + CCFC + INESSS Quebec + RAMQ: mesalamine + corticosteroids + biologics + vancomycin + fidaxomicin → reimbursed based on criteria |
| Colorectal cancer and screening Colorectal cancer with mucus bleeding — PQDCC screening — fecal immunochemical test (FIT) — colonoscopy — age 50 — family history — familial adenomatous polyposis (FAP) — Lynch HNPCC — TNM stages — surgical colonoscopy — postoperative surveillance |
Colorectal cancer (CRC) and mucus in the stool — the importance of screening: mucus and colorectal cancer: mucus in the stool associated with blood + or rectal bleeding + weight loss + abdominal pain + changes in bowel habits + iron-deficiency anemia → should raise suspicion of colorectal cancer untilproved otherwise → CRC is the second leading cause of cancer death in Canada and the third most common cancer in terms of incidence → colorectal cancer screening in Quebec (PQDCC): Quebec Colorectal Cancer Screening Program (PQDCC): fecal immunochemical test (FIT) → every 2 years for people aged 50 to 74 at average risk → if FIT is positive → colonoscopy within 60 days → high-risk screening: Personal history of adenomatous polyps or CRC → colonoscopy at frequent intervals + familial adenomatous polyposis (FAP): APC mutation → annual colonoscopy starting at age 10–12 → prophylactic colectomy often necessary → Lynch syndrome (HNPCC): MMR mutations (MLH1 + MSH2 + MSH6 + PMS2) + colonoscopy every 1–2 years starting at age 20–25 + 10 years before the family index case → clinical presentation of CRC: bleeding (melena or rectal bleeding) + mucus + changes in bowel habits (alternating + narrowing of stool diameter = pencil-thin stools) + abdominal pain + weight loss + unexplained iron-deficiency anemia + or palpable mass → colonoscopy + biopsies → thoraco-abdomino-pelvic CT scan (staging) → CRC treatment: according to TNM stages → surgery (hemicolectomy + colectomy) + chemotherapy (FOLFOX + FOLFIRI) + immunotherapy (pembrolizumab if MSI-H) + radiation therapy (rectum) → followed by monitoring (CEA + colonoscopy) → prognosis: stage I → 5-year survival >90% % → stage IV → <20% % | Rex 2017 — ACG guidelines: CRC + colonoscopy + screening + surveillance → reference Imperiale 2014 — NEJM: FIT + CRC screening → reference Siegel 2022 — CA Cancer Journal for Clinicians: CRC + incidence + mortality + prevention Winawer 1993 — NEJM (NPS trial): colonoscopy + polypectomy + CRC prevention Moreira 2012 — NEJM Lynch syndrome + PQDCC (Quebec Colorectal Cancer Screening Program): FIT + screening → Quebec reference INESSS Quebec + RAMQ: colonoscopy + FIT + TDM → reimbursed CCFC (Crohn's and Colitis Canada): IBD + CRC risk + surveillance |
ℹ️
Mucus isolated in the stool, without blood or other warning symptoms, in a young adult most often corresponds to irritable bowel syndrome (IBS) and does not require urgent endoscopic investigation: However, the presence of mucus with blood, a change in bowel habits, weight loss, or iron-deficiency anemia in a person over 45 years of age requires a colonoscopy to rule out colorectal cancer or IBD. Fecal calprotectin allows for rapid differentiation between an inflammatory cause (IBD) and a functional disorder (IBS). The Quebec Colorectal Cancer Screening Program (PQDCC) offers the FIT test every 2 years to people aged 50 to 74.
Situations requiring urgent or priority investigation
Mucus + rectal bleeding or melena + involuntary weight loss >5 kg + general deterioration + or iron deficiency anemia (Hb <100 g/L + low ferritin) + in a person over 45 years old → Priority: rule out colorectal cancer → Colonoscopy within 2-4 weeks + thoraco-abdomino-pelvic CT scan if a mass is palpable or if there are systemic signs → DO NOT wait 6 months for the colonoscopy.
Abundant mucus + bloody diarrhea + fever + abdominal pain + recent antibiotic therapy (within 2 months) → C. difficile colitis → C. difficile coproculture + toxin (EIA or PCR) → stop causative antibiotic → oral vancomycin 125 mg × 4/day × 10 days → or fidaxomicin 200 mg × 2/day → for severe forms (WBC >15,000 + rising creatinine + signs of megacolon) → hospitalization + possible surgery.
Very abundant mucus («liters» of watery mucus) + hypokalemia + dehydration + palpable rectal mass on digital rectal exam → Giant villous polyp of the rectum → Villous adenoma syndrome → Elective colonoscopy + CT scan → Endoscopic (mucosectomy + ESD) or surgical resection → Correction of IV hypokalemia.
Consult at Clinique Omicron
Clinique Omicron physicians assess for mucus in stool by looking for red flags (age + blood + weight loss + general decline + family history), perform digital rectal exams, prescribe appropriate investigations (CBC + CRP + ferritin + stool culture + fecal calprotectin + FIT), refer for colonoscopy if indicated, diagnose and treat IBS and infectious causes, participate in colorectal cancer screening (NCDSP + FIT), and coordinate with gastroenterologists for IBD and cancers. Consultations are available at several service locations in Quebec and via telemedicine. To book an appointment, visit cliniqueomicron.ca.
The content of this page is for informational purposes only and does not replace the advice of a doctor or gastroenterologist. Any mucus in the stool associated with blood, weight loss, changes in bowel habits, or iron deficiency anemia should undergo a complete medical investigation to rule out colorectal cancer or inflammatory bowel disease.
Omicron Clinic
Need to consult a doctor?
Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.
Insurance receipts. 7j/7. No family doctor required.